These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29414764)

  • 41. [Inhibitory effect of ketogenic diet on neuroblastoma in BALB/c-nu mouse models].
    He J; Lü L; Peng J; Li C; Kong X; Zhang J; Peng L
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1155-1164. PubMed ID: 32895178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature.
    Schwartz K; Chang HT; Nikolai M; Pernicone J; Rhee S; Olson K; Kurniali PC; Hord NG; Noel M
    Cancer Metab; 2015; 3():3. PubMed ID: 25806103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketogenic Diet Consumption Inhibited Mitochondrial One-Carbon Metabolism.
    Hsu FY; Liou JY; Tang FY; Sou NL; Peng JH; Chiang EI
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model.
    Morscher RJ; Aminzadeh-Gohari S; Feichtinger RG; Mayr JA; Lang R; Neureiter D; Sperl W; Kofler B
    PLoS One; 2015; 10(6):e0129802. PubMed ID: 26053068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of acetoacetyl-CoA synthetase in acetoacetate utilization by tumor cells.
    Tisdale MJ
    Cancer Biochem Biophys; 1984 Jun; 7(2):101-7. PubMed ID: 6147189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzyme activities support the use of liver lipid-derived ketone bodies as aerobic fuels in muscle tissues of active sharks.
    Watson RR; Dickson KA
    Physiol Biochem Zool; 2001; 74(2):273-82. PubMed ID: 11247746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketone body metabolism and its defects.
    Fukao T; Mitchell G; Sass JO; Hori T; Orii K; Aoyama Y
    J Inherit Metab Dis; 2014 Jul; 37(4):541-51. PubMed ID: 24706027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterozygous carriers of succinyl-CoA:3-oxoacid CoA transferase deficiency can develop severe ketoacidosis.
    Sasai H; Aoyama Y; Otsuka H; Abdelkreem E; Naiki Y; Kubota M; Sekine Y; Itoh M; Nakama M; Ohnishi H; Fujiki R; Ohara O; Fukao T
    J Inherit Metab Dis; 2017 Nov; 40(6):845-852. PubMed ID: 28695376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet.
    Voss M; Lorenz NI; Luger AL; Steinbach JP; Rieger J; Ronellenfitsch MW
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30127309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fat not so bad? The role of ketone bodies and ketogenic diet in the treatment of endothelial dysfunction and hypertension.
    Pirola L; Ciesielski O; Balcerczyk A
    Biochem Pharmacol; 2022 Dec; 206():115346. PubMed ID: 36384215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ketone bodies in epilepsy.
    McNally MA; Hartman AL
    J Neurochem; 2012 Apr; 121(1):28-35. PubMed ID: 22268909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ketone bodies inhibit the viability of human neuroblastoma cells.
    Skinner R; Trujillo A; Ma X; Beierle EA
    J Pediatr Surg; 2009 Jan; 44(1):212-6; discussion 216. PubMed ID: 19159745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.
    Vallejo FA; Shah SS; de Cordoba N; Walters WM; Prince J; Khatib Z; Komotar RJ; Vanni S; Graham RM
    J Neurooncol; 2020 Apr; 147(2):317-326. PubMed ID: 32096068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. β hydroxybutyrate levels in serum and cerebrospinal fluid under ketone body metabolism in rats.
    Wang X; Liu Q; Zhou J; Wu X; Zhu Q
    Exp Anim; 2017 May; 66(2):177-182. PubMed ID: 28100888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. β-hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells.
    Maldonado R; Talana CA; Song C; Dixon A; Uehara K; Weichhaus M
    Oncol Lett; 2021 Jan; 21(1):65. PubMed ID: 33281976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Untargeted Metabolomics Reveals Molecular Effects of Ketogenic Diet on Healthy and Tumor Xenograft Mouse Models.
    Licha D; Vidali S; Aminzadeh-Gohari S; Alka O; Breitkreuz L; Kohlbacher O; Reischl RJ; Feichtinger RG; Kofler B; Huber CG
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.
    Seyfried TN; Sanderson TM; El-Abbadi MM; McGowan R; Mukherjee P
    Br J Cancer; 2003 Oct; 89(7):1375-82. PubMed ID: 14520474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketone body oxidation increases cardiac endothelial cell proliferation.
    Weis EM; Puchalska P; Nelson AB; Taylor J; Moll I; Hasan SS; Dewenter M; Hagenmüller M; Fleming T; Poschet G; Hotz-Wagenblatt A; Backs J; Crawford PA; Fischer A
    EMBO Mol Med; 2022 Apr; 14(4):e14753. PubMed ID: 35179309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Ketogenic Diet on Muscle Metabolism in Health and Disease.
    Yakupova EI; Bocharnikov AD; Plotnikov EY
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer.
    Vergati M; Krasniqi E; Monte GD; Riondino S; Vallone D; Guadagni F; Ferroni P; Roselli M
    Curr Med Chem; 2017; 24(12):1170-1185. PubMed ID: 28093985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.